CompletedNot Applicable

Margin Status After Pancreaticoduodenectomy for Cancer

168 participantsStarted 2013-03

Plain-language summary

This multicentric prospective randomized controlled trial (RCT) compares the Leeds Pathology Protocol (LEEPP) with other "conventional" pathological protocol of PD specimen for periampullary cancer. Our aims were to evaluate the impact of the protocol and of the clearance on R1 rate and its prognostic value.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * pancreaticoduodenectomy for periampullary cancer Exclusion Criteria: * diagnosis of neuroendocrine neoplasm; * previous pancreatic surgery; * frozen section of each transection margins not performed or presence of positive transection margins without further resection (R1 intraoperative resection); * presence of macroscopic residual tumor (R2 resection).

What they're measuring

R1 resection rate

Timeframe: 1 month

Trial details

NCT IDNCT03267966

SponsorCampus Bio-Medico University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-06

View on ClinicalTrials.gov More Pancreatic Cancer trials